Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

These ASX shares are starting the week strongly.

| More on:
An investor sits at her desk and stretches her arms above her head in delight.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is currently down 0.9% to 7,272.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is up 9% to $2.28. Investors have been buying this baby products retailer's shares after analysts at Morgans upgraded them to an add rating with a $2.50 price target. The broker made the move after increasing its earnings estimates to reflect cost reductions and a better sales outlook.

Carsales.Com Ltd (ASX: CAR)

The Carsales share price is up 6% to $26.11. This follows the release of the auto listings company's FY 2023 results. Carsales reported an 18% increase in pro forma revenue and a 43% lift in adjusted net profit after tax to $278.2 million. Looking ahead, management expects "to deliver good growth in Revenue and [pro forma] EBITDA in FY24" and an "expansion in the carsales Group EBITDA margin."

GWA Group Ltd (ASX: GWA)

The GWA share price is up 7% to $2.06. This has been driven by the release of the building fittings company's full-year results. GWA reported a 22.7% increase in statutory net profit to $43.2 million. Management commented: "GWA delivered a solid result for FY23 within a rapidly evolving operating environment that comprised two distinct halves."

Imugene Limited (ASX: IMU)

The Imugene share price is up 3.5% to 9.2 cents. This morning, this immuno-oncology company announced that its Phase 1 MAST (metastatic advanced solid tumours) trial evaluating the safety of novel cancer-killing virus CF33- hNIS (VAXINIA) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Carsales.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Bravura, HMC, Magellan, and Perseus shares are pushing higher today

These shares are having a good session on Thursday. But why?

Read more »

A businessman stacks building blocks.
Technology Shares

Why has this ASX 200 tech stock rocketed 38% in a month?

The stars aligned for this stock over the past month.

Read more »

Three rockets heading to space
Share Gainers

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Investors are sending these three ASX biotech stocks flying higher on Thursday.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a red day for the markets this Wednesday.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why 4DMedical, Bravura, GQG Partners, and Pro Medicus shares are storming higher

These shares are having a good session on hump day. But why?

Read more »

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another day and another record high for ASX shares.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Share Gainers

This small-cap ASX healthcare stock just exploded 131%! Here's why

Investors are sending the ASX small-cap healthcare stock soaring on Tuesday.

Read more »

Five people in an office high five each other.
Share Gainers

Why Life360, Metcash, Star Entertainment, and Westpac shares are pushing higher

These shares are having a strong session on Tuesday. But why?

Read more »